Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT07190690 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

2100

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: ihtDEStiny® DES implanted
DEVICE: Xience™ DES implanted

Sponsor

Fundación EPIC